Clinical trials: Masked Hypertension
Hypertension
Real-World Validation of Huawei Wearable Technologies for Hypertension Risk Screening in Malaysia
Background: Hypertension (high blood pressure) is a major risk factor for heart disease and stroke, yet many people do not know they have it.
- Trial name
- Huawei-SunU1 (NCT07785895)
- Where
- Malaysia
- Volunteers
- 500 people, healthy volunteers welcome
- Sponsor
- Sunway University
Cardiovascular Diseases, Heart Diseases
Psychosocial Factors and Cardiovascular Disease
To evaluate the role of psychosocial factors in the development of hypertension and cardiovascular disease. To estimate the prevalence of masked hypertension and its potential role in the development of subclinical cardiovascular…
- Conditions
- Cardiovascular Diseases, Heart Diseases, Hypertension
- Trial name
- NCT00005315
- Volunteers
- 893 people, healthy volunteers welcome
- Sponsor
- Columbia University
Prehypertension, Masked Hypertension
Arterial Function After Two Different Physical Exercise Intensities in Prehypertension
Individuals with prehypertension, diagnosed according to the 7th Brazilian Guidelines on Hypertension with the presence of systolic blood pressure (SBP) between 121 and 139 and / or diastolic (DBP) between 81 and 89 mmHg, are…
- Trial name
- PREHTEXVAS (NCT04200716)
- Testing
- Moderate intensity continuous training - session, High intensity interval training - session
- Where
- Brazil
- Volunteers
- 22 people, healthy volunteers welcome
- Sponsor
- University of Sao Paulo General Hospital
Masked Hypertension
Screening for Masked Hypertension With Smart Wearable Devices (SMART)
In recent years, a large number of consumer-grade and Smart Wearable Devices (SWD) such as smart watches, with BP measurement property, have entered the market and have a high configuration and utilization among young and…
- Trial name
- SMART (NCT05409898)
- Testing
- smart wearable device
- Where
- China
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Jing Liu
Obstructive Sleep Apnea
Cardiovascular Impact of Obstructive Sleep Apnea Treatment in Normotensive Patients
Recent evidences suggest that obstructive sleep apnea (OSA) can contribute to cardiovascular disease even in the absence of hypertension.
- Trial name
- OSA-NORMO (NCT00741520)
- Testing
- CPAP
- Where
- Brazil
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- University of Sao Paulo